In our mice, regardless of Sirt1 genotype, mammary tumors all had similar levels of SIRT1 and ERα protein levels as assessed by immunohistochemistry, suggesting that absence of SIRT1 catalytic activity does not appear to affect ERα expression in this context. The gene discussed is SIRT1; the disease is breast cancer.